D&O Ongoing Disclosure - A Waugh
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer: Seeka Kiwifruit Industries Limited
Date this disclosure made:14-Nov-24
Date of last disclosure: 29-May-20
Director or senior manager giving disclosure
Full name(s):Ashley James Waugh
Name of listed issuer:Seeka Kiwifruit Industries Limited
Name of related body corporate (if applicable):NA
Position held in listed issuer:Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: Ordinary Shares
Nature of the affected relevant interest(s):
Registered holder and beneficial owner of Ordinary Shares
held by Ashley James Waugh
For that relevant interest-
Number held in class before acquisition or disposal:13,166 Ordinary Shares
Number held in class after acquisition or disposal:2,866 Ordinary Shares
Current registered holder(s):
Registered holder and beneficial owner of Ordinary Shares
held by Ashley James Waugh
Registered holder(s) once transfers are registered:NA
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative: NA
Class of underlying financial products:NA
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if
any):
NA
A statement as to whether the derivative is cash settled or physically settled:NA
Maturity date of the derivative (if any):NA
Expiry date of the derivative(if any):NA
The price specified in the terms of the derivative (if any):NA
Any other details needed to understand how the amount of the consideration payable under the
derivative or the value of the derivative is affected by the value of the underlying financial products:
NA
For that derivative,-
Parties to the derivative:
NA
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in
the derivative:
NA
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:
16
Details of transactions requiring disclosure-
Date of transaction:
11 November 2024 and 12 November 2024
Nature of transaction:
On Market Sale
Name of any other party or parties to the transaction (if known):
NA
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal.
If the consideration was not in cash and cannot be readily by converted into a cash value, describe
the consideration:
$28,020.68 (10,300 Ordinary Shares at an average price of
$2.7205 per share)
Number of financial products to which the transaction related:
10,300 Ordinary Shares
If the issuer has a financial products trading policy that prohibits directors or senior managers from
trading during any period without written clearance (a closed period) include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
NA
Whether prior written clearance was provided to allow the acquisition or disposal to proceed during
the closed period:
NA
Date of the prior written clearance (if any):NA
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
NA
Nature of relevant interest:
NA
For that relevant interest,-
Number held in class:
NA
Current registered holder(s):
NA
For a derivative relevant interest,-
Type of derivative:
NA
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if
any):
NA
A statement as to whether the derivative is cash settled or physically settled:NA
Maturity date of the derivative (if any):NA
Expiry date of the derivative (if any):NA
The price's specified terms (if any):NA
Any other details needed to understand how the amount of the consideration payable under the
derivative or the value of the derivative is affected by the value of the underlying financial products:
NA
For that derivative relevant interest,-
Parties to the derivative:
NA
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in
the derivative:
NA
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this disclosure is
correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
N Reynolds
Date of signature:14-Nov-24
Name and title of authorised person:Acting Chief Financial Officer
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- NZK — New Zealand King Salmon Investments Limited: Ongoing Disclosure Notice - Various2024-10-16
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: New Zealand King Salmon Investments Limited Date this disclosure made: 16-Oct-24 D…”
- TAH — Third Age Health Services Limited: D&O Ongoing Disclosure – Bevan John Walsh2025-01-17
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Third Age Health Services Limited Date this disclosure made: 17 January 2025 Date…”
- TAH — Third Age Health Services Limited: D&O Ongoing Disclosure – Bevan John Walsh2025-01-28
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Third Age Health Services Limited Date this disclosure made: 29 January 2025 Date…”